NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT00031915 2013-06-19Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone SarcomaNational Cancer Institute (NCI)Phase 2 Completed